Pamidronic acid
- Generic Name
- Pamidronic acid
- Brand Names
- Pamisol
- Drug Type
- Small Molecule
- Chemical Formula
- C3H11NO7P2
- CAS Number
- 40391-99-9
- Unique Ingredient Identifier
- OYY3447OMC
- Background
Pamidronic acid is a second generation, nitrogen containing bisphosphonate similar to neridronic acid and alendronic acid. Pamidronic acid was first described in the literature in 1977. The second generation bisphosphonates are less common as third generation bisphosphonates, such as ibandronic acid, zoledronic acid, minodronic acid, and risedronic acid are ...
- Indication
Pamidronate is indicated to treat moderate to severe hypercalcemia of malignancy, moderate to severe Paget's disease of bone, osteolytic bone metastases of breast cancer, and osteolytic lesions of multiple myeloma.
- Associated Conditions
- Hypercalcemia of Malignancy, Osteolytic lesion, Paget’s Disease, Osteolytic Bone metastases
- Associated Therapies
- -
Pamidronate for pain in adult chronic nonbacterial osteitis (PAM-CNO)
Pamidronate for pain in adult chronic nonbacterial osteitis (PAM-CNO): protocol of a randomized, double-blind, placebo-controlled trial.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath